glp 1 kidney protection Glucagon-like Peptide-1 Receptor Agonists and Diabetic Disease: From Bench to Bed-Side Kidney Protection Diabetes: Early Use
Description
It supports metabolic health and encourages steady weight loss

Patients have reported decreased interest in alcohol and nicotine when taking GLP-1s, and observational studies have shown an association between treatment with GLP-1 medication and lower risk of alcohol and cannabis use disorders, opioid overdose, and alcohol-related hospitalization

Optimization Plan: Perfect for clients whove reached their goal weight and are focused on weight management and building lasting habits for long-term health

[DOI] [PMC free article] [PubMed] [Google Scholar] 52.Ben-Shlomo S, Zvibel I, Shnell M, Shlomai A, Chepurko E, Halpern Z, et al

& Simon, M

Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-B pathway
